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PPAR isotypes are involved in the regulation of cell proliferation, death, and diﬀerentiation, with diﬀerent roles and mechanisms
dependingonthespeciﬁcisotypeandligandandonthediﬀerentiated,undiﬀerentiated,ortransformedstatusofthecell.Diﬀeren-
tiation stimuli are integrated by key transcription factors which regulate speciﬁc sets of specialized genes to allow proliferative cells
to exit the cell cycle and acquire specialized functions. The main diﬀerentiation programs known to be controlled by PPARs both
duringdevelopmentandintheadultareplacentaldiﬀerentiation,adipogenesis,osteoblastdiﬀerentiation,skindiﬀerentiation,and
gut diﬀerentiation. PPARs may also be involved in the diﬀerentiation of macrophages, brain, and breast. However, their functions
in this cell type and organs still awaits further elucidation. PPARs may be involved in cell proliferation and diﬀerentiation pro-
cesses of neural stem cells (NSC). To this aim, in this work the expression of the three PPAR isotypes and RXRs in NSC has been
investigated.
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1. INTRODUCTION
Peroxisome proliferator-activated receptors (PPARs) are li-
gand-activated transcription factors belonging to the nu-
clearhormonereceptorsuperfamily[1].Aftertheisolationof
PPARα (NR1C1) as the receptor mediating peroxisome pro-
liferation in rodent hepatocytes in 1990 [2], two related iso-
types, PPARβ/δ (NR1C2; referred to as PPARβ herein) and
PPARγ (NR1C3), have been characterized[3]. PPARs exhibit
a broad but isotype-speciﬁc tissue expression pattern which
canaccountforthevarietyofcellularfunctionstheyregulate.
PPARα is expressed in tissues with high fatty acid catabolism
such as the liver, the heart, the brown adipose tissue, the kid-
ney,andtheintestine.ThetwoPPARγ isoformsγ1andγ2act
in the white and brown adipose tissues to promote adipocyte
diﬀerentiationandlipidstorage[4]whileonlytheexpression
of PPARγ1 extends to other tissues such as the gut or im-
mune cells. PPARβ has a broad expression being detected in
all tested tissues but important functions have been assigned
to this isotype in the skeletal muscle, the adipose tissue, the
skin, the gut, and the brain.
PPARs are sensors capable of adapting gene expression to
integrate various lipid signals. The diversity of functions in
which they are implicated is also reﬂected by the diversity of
ligands that can be accommodated within their ligand bind-
ing pocket. Indeed, PPARs are activated by a wide range of
naturally occurring or metabolized lipids derived from the
diet or from intracellular signaling pathways, which include
saturated and unsaturated fatty acids and fatty acid deriva-
tives such as prostaglandins and leukotriens [5, 6].
In contrast to steroid hormone receptors which act as
homodimers, PPARs activate the transcription of their tar-
get genes as heterodimers with retinoid X receptors (RXR,
NR2B) [7, 8]. The three RXR isotypes (α, β,a n dγ)c a n
dimerize with PPARs, and speciﬁc association with each iso-
type seems to inﬂuence the recognition of target gene pro-
moters [9]. However, very little is known on the speciﬁcity
of RXR isotype utilized by the diﬀerent PPARs in vivo. The
observation that 9-cis retinoic acid and synthetic RXR ag-
onists can promote the transcription of PPAR target genes
leads to a model of permissive transcriptional activation
where PPAR/RXR heterodimers can induce transcription in
responsetoPPARorRXRactivation[10,11].Moreover,con-
comitant treatment with both PPAR and RXR agonists po-
tentiates the eﬀects observed with each ligand alone. How-
ever, the molecular mechanisms underlying transcriptional
permissivity and synergy are not well understood in terms
of cofactor recruitment by each partner of the heterodimer.2 PPAR Research
Table 1: Primers and PCR cycling. The adopted sequences of speciﬁc primers and relative cycling conditions of each RT-PCR are indicated.
Gene Gene bank number Size (bp) Sequence Annealing (◦C) Cicles
PPAR α Gazouli et al., 2002 741 F5  ggtcaaggcccgggtcatactcgcagg3 
69 40
R5  tcagtacatgtctctgtagatctct3 
PPAR β Gazouli et al., 2002 130 F5  gtcatggaacagccacaggaggagacccct3 
69 40
R5  gggaggaattctgggagaggtctgcacagc3 
PPAR δ Gazouli et al., 2002 421 F5  gagatgccattctggcccaccaacttcgg3 
69 40
R5  tatcataaataagcttcaatcggatggttc3 
β -Actin NM 031144 661 F5  tgacggggtcacccacactgtgcccatcta3 
65 28
R5  ctagaagcattgcggtggacgatggaggg3 
(a) (b) (c)
Figure 1:Contrastphasemicroscopyofneuralstemcellsgrowinginneurospheres(a).In(c),BrdUincorporationisshown.Hoechstnuclear
staining of the same ﬁeld is shown in (b). Bar = 40μm.
Finally, the interplay between PPAR and RXR pathways is
furtherillustratedbyPPARtargetgeneactivationinresponse
to RXR homodimers [12].
Cellular proliferation allows the renewal of tissues by
providingapoolofundiﬀerentiatedcellsorprogenitorsfrom
stem cells. All three PPAR isotypes are involved in the regu-
lation of cell proliferation, death, and diﬀerentiation, with
diﬀerent roles and mechanisms depending on the speciﬁc
isotype and ligand and on the diﬀerentiated, undiﬀerenti-
ated, or transformed status of the cell. Thus, proliferative
and antiapoptotic or antiproliferative, prodiﬀerentiating and
proapoptotic eﬀects, and even procarcinogenic eﬀects have
been reported for PPARs [13].
Diﬀerentiation stimuli are integrated by key transcrip-
tion factors which regulate speciﬁc sets of specialized genes
to allow proliferative cells to exit the cell cycle and acquire
specialized functions. The main diﬀerentiation programs
known to be controlled by PPARs both during development
and in the adult are placental diﬀerentiation, adipogenesis,
osteoblast diﬀerentiation, skin diﬀerentiation, and gut
diﬀerentiation. PPARs may also be involved in the diﬀer-
entiation of macrophages, brain, and breast [14]. However,
their functions in this cell type and organs still await further
elucidation.
In astroglial cells, we have demonstrated the involvement
of PPARα in astrocytic diﬀerentiation [14]. The expression
of PPARβ i nt h eb r a i np e a k sb e t w e e nd a y s1 3 . 5a n d1 5 . 5
of rat embryonic development [15]. The role of PPARβ in
the development of the central nervous system is further il-
lustrated by the myelination defects of the corpus callosum
observed in PPARβ null mice [16]. However, the outputs in
terms of brain development and the mechanisms regulating
the potential implication of PPARβ in the diﬀerentiation of
cerebral cells are unknown. Recently we have demonstrated
that PPARβ expression and activation are increased during
neuronal in vitro maturation, thus suggesting a role for this
transcription factor in this process [17]. Moreover, we have
demonstrated that PPARβ agonists trigger neuronal diﬀer-
entiation in a human neuroblastoma cell line [18]. Very re-
cently we found that PPARβ activation by the synthetic ago-
nist GW0742 leads to early neuronal maturation and BDNF
increase, thus suggesting a role for PPARβ in neuronal plas-
ticity (Benedetti et al., manuscript in preparation).
On the basis of the previous evidences, we hypothesize
that PPARs may be involved in cell proliferation and diﬀer-
entiation processes of neural stem cells (NSC). To this aim,
the expression of the three PPAR isotypes and RXRs in NSC
has been investigated.
2. MATERIALS AND METHODS
2.1. Materials
CD1 mice were from Charles River (Harlan, Lecco, Italy);
fetal bovine serum (FBS) and Earl’s balanced salt solution
(EBSS) were obtained from Invitrogen SRL (Milan, Italy);
papain was from Worthington Biochemical (Lakewood, NJ,
USA); the culture media was a kind gift of Dr Rosella Galli
SCRI-DIBIT (Milan, Italy);EGF and bFGF were from Pepro-
tech (Rocky Hill, NJ, USA); matrigel basement membrane
matrix-GFR was from Becton Dickinson (Lincoln Park, NJ,
USA); BCA protein detection kit from Pierce (Rockford,A. Cimini et al. 3
(a) (b) (c)
(d) (e)
Figure 2: Immunolocalization in S0 neurospheres of nestin (b) and PLP (e). Nuclear staining of the same ﬁeld is shown in (a) and (d),
respectively. Double A2B5/Hoechst immunostaining is shown in (c). Bar = 70μm
Ill, USA); antinestin (RAT 401) antibody was from Devel-
opmental Studies Hybridoma Bank (DSHB) (University of
I o w a ,I o w aC i t y ,I o w a ,U S A ) ;m o u s ea n t i - P L Pa n d - A 2 B 5
antibodies were from Chemicon International Inc. (Temec-
ula, Calif, USA); mouse anti-β-tubulin III antibody was
from Promega (Mannheim, Germany); rabbit polyclonal
anti-PPAR α, β/δ, γ antibodies were both from Aﬃnity
Bioreagents Inc. (Golden, Colo, USA) and from Santa Cruz
Biotechnology, Inc. (Santa Cruz, Calif, USA); ECL kit was
from Amersham Life Sciences (Little Chalfont, Bucking-
hamshire, UK); vectashield mounting medium from Vector
Laboratories (Burlingame, Calif, USA); trizol reagent and
platinum Taq DNA polymerase were from Invitrogen. Kit
Gene Speciﬁc Relative RT-PCR was from Ambion (Austin,
Tex, USA). All other chemicals were from Sigma Aldrich (St.
Louis, Mo, USA).
2.2. Primarycultureandculturepropagation
differentiation
Adult CD1 Swiss-Albino mice were killed by cervical dislo-
cation and their brains removed and placed into PBS with
penicillin and streptomycin (0.1mg/mL). The tissues con-
taining the forebrain periventricular region SVZ were dis-
sected and incubated in Earl’s balanced salt solution (EBSS)
containing papain (1mg/mL), EDTA (0.2mg/mL), and cys-
tein (0.2mg/mL) at 37◦C for 1hour. The pieces of tissue
were collected by centrifugation at 200g for 5minutes and
resuspended in 1mL of the DMEM/ F12 containing 0.7mg
of ovomucoid inhibitor. The cells were dissociated using a
ﬁre-polished Pasteur pipette and were collected by centrifu-
gation at 300g for 5minutes. The cellular pellets were re-
suspended in DMEM/F12 containing HEPES buﬀer (5mM),
glucose (0.6%), sodium bicarbonate (3mM), L-glutamine
(2mM), insulin (25mg/mL), putrescine (60μM), apotrans-
ferrin (100μM), progesterone (6.3ng/mL), sodium selenite
(5.2ng/mL), heparin (2μg/mL), EGF (20ng/mL), and bFGF
(10ng/mL), counted and plated in uncoated 25cm2 ﬂask at
8 ×103cells/cm2.
Neurospheres were passaged by harvesting them by cen-
trifugation (200g for 5minutes) and triturating them in
200μL of medium with an automatic pipetter (P200 Gilson).
2.3. Differentiationofstemcellprogenyand
immunoﬂuorescence
For diﬀerentiation, neurospheres were plated onto Matrigel
basement membrane matrix-coated (100μg/mL) well in the
medium described above with addition of FBS (10%) with-
out EGF and bFGF for 5days (S10).
Indiﬀerentiated (S0) and diﬀerentiated (S10) neuro-
spheres grown on Matrigel GFR glass coverslips were ﬁxed
with 4% paraformaldehyde in phosphate buﬀered saline
(PBS) for 10minutes at room temperature (RT) and per-
meabilized with 0.1% Triton X-100 in PBS for 5minutes at
RT. Nonspeciﬁc binding sites were blocked with 10% bovine
serum albumin (BSA); in PBS, for 10minutes at RT. This
procedure was performed prior to incubation with primary
antibodies, except when the A2B5 or the O4 mouse mono-
clonal antibodies were used. In this case, ﬁxation followed
incubation.
For single immunoﬂuorescent staining, cells were in-
cubated with either of the following primary antibodies:
1:5 mouse monoclonal antinestin, 1:200 mouse monoclonal
antiglial ﬁbrillary acidic protein (GFAP), 1:300 mouse mon-
oclonal anti-β-tubulin III, 1:30 mouse monoclonal PLP,
1:100 rabbit polyclonal anti-PPARα, β/δ , γ, and with 1:200
antimouse monoclonal A2B5 and O4 overnight at 4◦C. All
the slides were then incubated with ﬂuorescein isothio-
cyanate (FITC)-conjugated goat antirabbit IgG, antimouse
IgG, or antimouse IgM antibodies (1:100), for 30minutes at
RT.4 PPAR Research
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Figure 3: PPARs immunolocalization in S0 neurospheres. (b)
PPARα,( d )P P A R β,( f )P P A R γ. Hoechst nuclear staining is shown
in (a), (b), and (c), respectively. Bar = 20μm.
Both primary and secondary antibodies were diluted
with PBS containing 10% BSA. Controls were performed by
substituting the primary antibody with PBS-BSA, containing
or not rabbit nonimmune serum.
Double immunoﬂuorescence with anti-A2B5 and anti-
GFAP antibodies was performed as described. Brieﬂy, cells
were ﬁrst incubated with 1:100 anti-A2B5, then ﬁxed with
4% paraformaldehyde in phosphate buﬀered saline (PBS),
and incubated with 1:100 secondary FITC-conjugated goat
anti-IgM antibodies. Subsequently, the cells were permeabi-
lized with 0.1% Triton X-100 in PBS for 5minutes at RT
and incubated with 1:200 mouse monoclonal antiglial ﬁb-
rillary acidic protein (GFAP), followed by 1:100 secondary
tetramethylrhodamine isothiocyanate (TRITC)-conjugated
antirabbit IgG. The nuclei were stained with 0.5μm/mL
Hoechst33258dilutedineachsecondaryantibodiesmixture.
Coverslips were mounted with Vectashield mounting
medium and examined in a Zeiss Axioplan 2 ﬂuorescence
microscope.
2.4. ImmunocytochemistryoilredOstaining
Indiﬀerentiated (S0) and diﬀerentiated (S10) neurospheres
g r o w no nM a t r i g e lG F Rg l a s sc o v e r s l i p sw e r eﬁ x e dw i t h
10% formaline in PBS for 10minutes at room temperature
(RT) and permeabilized with 0.1% Triton X-100 in PBS for
5minutes at RT. Nonspeciﬁc binding sites were blocked with
PBS containing 10% BSA for 30minutes at RT. Immunocy-
tochemistry staining was performed with mouse antinestin
(1:5) and anti-GFAP 1:2000 in PBS containing 10% BSA
for 1hour at RT and then with peroxidase-conjugated an-
timouse IgG secondary antibodies (1:200 in PBS contain-
ing 10% BSA) for 30minutes at RT; the immunoreactivity
was detected with the 3,3 diaminobenzidine (DAB) reaction.
Subsequently, the oil red O staining was performed by the
method of Diascro et al. (1998), with minor modiﬁcations.
Brieﬂy, the cells were stained with 0.35% oil red O, for 1hour
at RT. The working solution of oil red O was prepared as de-
scribed by Ramirez-Zacarias et al. [19].
After washing with distilled water, cells were counter-
stained with Mayer’s hematoxylin and allowed to air dry.
Coverslips were mounted with Kaiser’s glycerol gelatin and
observed with a Leitz Wetzlar Ortholux light microscope.
2.5. Proteindetection
For cell lysis, 107 cells were suspended in 150μLo fR I P A
lysis buﬀer containing NaF [100mM], Na4P2O7 [2mM],
Na3VO4 [2mM], NP-40 [1%], SDS [0.1%], EDTA [5mM],
DOC [0.5%], protease inhibitor cocktail, in PBS 1x solution.
The lysates were cleared by centrifugation at 12000rpm for
20minutes.
Protein concentration was determined by BCA protein
assaykit,usingbovineserumalbuminasastandard.Samples
(20/50μg protein) were run on 10%–15% polyacrylamide
denaturing gels according to Laemmli [20]. Protein bands
were transferred on polyvinylidene diﬂuoride (PVDF) sheets
by wet electrophoretic transfer according to Towbin et al.
[21]. Nonspeciﬁc binding sites were blocked for 1hour at
room temperature with 5% nonfat dry milk in Tris-buﬀered
salinecontaining0.25%Tween20(TBS-T).Membraneswere
incubated with the primary antibody at the appropriate di-
lutions [1:50 for mouse antinestin, 1:1000 mouse anti-GFAP,
1:2000 rabbit antiactin, rabbit anti-PPARα, β, γ] overnight
at +4◦C in blocking solution, followed by incubation with
HP-conjugated secondary antibody (antirabbit; antimouse),
at the appropriate dilution (1:2000 in blocking solution), for
1hourat4 ◦C. After rinsing, the speciﬁc immune complexes
were detected by ECL method. Band relative densities were
determined and normalized using a semiquantitative densit-
ometric analysis and values are given as relative units.
2.6. RT-PCR
Total cellular RNA was extracted by trizol reagent (Invitro-
gen) according to the manufacturer’s instructions. The to-
tal RNA concentration was determined spectrophotometri-
cally in RNAase-free water and 1μg aliquots of total RNA
were reverse transcribed into cDNA using Kit Gene Speciﬁc
Relative RT-PCR. After RT 2μL of the cDNA was used as
template in 20μL of PCR mixture and Taq platinum. The
number of cycles was obtained empirically by sampling the
PCR ampliﬁcation of positive control between 22 and 40
cycles and selecting the approximate midpoint of a linearA. Cimini et al. 5
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Figure 4: Western blotting and relative densitometric analysis in S0 neurosphere cell lysates. An example of western blotting is shown.
Densitometric data are means ± SD of 5 diﬀerent experiments.
ampliﬁcation. Table 1 reports primers sequences and ampli-
ﬁcationconditionsforeachgenestudied.β-Actinwasusedas
internal control and used for normalization. PCR products
were separated by electrophoresis on 2% agarose gels con-
taining ethidium bromide (0.5μg/mL) in Tris-borate EDTA
buﬀer. A molecular weight marker was run in parallel and
bands of the expected molecular size were detected under
UV light. The relative densities of the PCR fragments were
determined and normalized using a semiquantitative densit-
ometric analysis and values are given as relative units.
2.7. Statistics
Statistical analysis for multiple comparisons was performed
by one-way ANOVA followed by Scheﬀe’s post hoc test. All
statistical calculations were performed using SPSS software.
P values <.05 were considered statistically signiﬁcant.
3. RESULTS
In Figure 1, contrast phase microscopy of neural stem cells
growing in neurospheres (Figure 1(a)) and after BrdU in-
corporation (Figure 1(c)) are shown. Nuclear staining with
Hoechst 33258 (Figure 1(b)) clearly shows that almost all
cells appear positive for BrdU indicating that they are mi-
totic in our experimental conditions. Since the proliferation
ability is not only exclusive of stem cells, but is shared with
progenitors of diﬀerent lineages, markers of indiﬀerentiated
status have also been investigated.
The immunolocalization of nestin (Figure 2(b))a sc o m -
pared with Hoechst nuclear staining (Figure 2(a)) shows
that almost all cells are immunopositive for nestin, which
is asymmetrically concentrated in the perinuclear region.
Proteolipid protein (PLP) immunolocalization Figure 2(e),
membrane protein of indiﬀerentiated status, shows that
almost all cells appear immunopositive for PLP (com-
pare with Figure 2(d)). Only few cells are immunoposi-
tive for A2B5, marker of astroglial restricted precursors
(Figure 2(c)). GFAP, β tubulin III, and O4, markers of as-
trocytes, neurons, and oligodendrocytes, respectively, are not
expressed (not shown).
Figure 3 shows the immunolocalization of the three
PPAR isotypes in neurospheres. Nuclear staining of the same
ﬁelds is shown in Figures 3(a), 3(b),a n d3(c). All the three
PPARs are present, almost exclusively localized in the nuclei.
See Figures (3(b), 3(d), 3(f)).
Western blotting analysis for nestin, GFAP, PPARα, β,
and γ, and RXRs in neurosphere cell lysates conﬁrms the
presence of the three PPARs and shows that the only RXR
isotype detectable in these cells is the RXRβ (Figure 4).
To assess the possible quantitative/qualitative varia-
tions of the receptors during diﬀerentiation, neurospheres
were cultured in absence of growth factors and in the
presence of 10% FBS for 5days (S10). Figure 5 shows the6 PPAR Research
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Figure 5: Immunolocalization of nestin, A2B5, and GFAP in S10
neurospheres. In (a), (b), and (c), double immunostaining of
nestin/Hoechst, A2B5/Hoechst, and GFAP/Hoechst is shown, re-
spectively. In (d), (e), and (f), the single immunostaining is shown.
Bar = 40μm.
immunolocalization of the above-mentioned diﬀerentiation
markers in S10 neurospheres. Nestin is still expressed, but
with lower Fuorescence intensity (Figures 5(a) and 5(b)).
Moreover, the protein is no more concentrated in the perin-
uclear region, but unifromely localized throughout the cyto-
plasm, including the cellular processes; the number of A2B5
immunopositivecellsappearsslightlyincreased(Figures5(b)
and 5(e)), while a clear immunoﬂuorescence for GFAP (Fig-
ures 5(c) and 5(f))i so b s e r v e di nm a n yS 1 0c e l l s .β-Tubulin
III and O4 are absent (not shown).
These results demonstrated that, in our diﬀerentiating
conditions, S10 neurospheres are mainly composed by dif-
ferentiated astrocytes and their A2B5 precursors.
In Figure 6, double immunoﬂuorescence staining for
GFAP and PPARs in S10 neurospheres is shown. In these
cells the PPARs are still present but with diﬀerent ﬂuo-
rescence intensity. In particular, PPARα immunostaining
(Figure 6(a))i ss t r o n g e r ,w h i l eP P A R β appears weaker than
in S0 neurospheres (Figure 6(b)); PPARγ appears unchanged
(Figure 6(c)).
Figure 7 shows the western blotting analysis for nestin,
GFAP, PPARs, and RXRs in S0 and S10 neurosphere cell
lysates. In S10 cells, nestin is signiﬁcantly decreased, while
GFAP is strongly expressed. Interestingly, RXRα,n o tp r e s e n t
in S0 neurospheres, is now detected while RXRβ is un-
(a)
(b)
(c)
Figure 6: Double immunoﬂuorescence staining for GFAP/PPAR in
S10 neurospheres is shown. (a) PPARα,( b )P P A R β,( c )P P A R γ.B a r
= 30μm.
changed. In agreement with the immunoﬂuorescence data,
PPARβ is strongly decreased and PPARγ appears unchanged;
concerningPPARα,nosigniﬁcantquantitativediﬀerencesare
observed.
TheRT-PCRanalysisofPPARmRNAsinS0andS10neu-
rospheres (Figure 8) shows that, during astroglial diﬀerenti-
ation, PPARα is signiﬁcantly increased while PPARβ expres-
sion is signiﬁcantly decreased. PPARγ appears unchanged.
Figure 9showsthedoublestainingofoilredpositivelipid
droplets and nestin in S0 (Figure 9(a))a n do i lr e d / G F A Pi n
S10 (Figure 9(b)) neurospheres. Nuclei were counterstained
with Mayer heamallume. In S0 neurospheres, almost all im-
munoreactive nestin cells show several lipid droplets in their
cytoplasm, some of which being very large. In S10 GFAP-
positive cells, lipid droplets are no more observed.
4. DISCUSSION
In this paper, the presence of all three isotypes of PPARs in
mouse adult neural stem cells has been established for the
ﬁrst time. Moreover, we demonstrated that PPARs are sub-
jected to both quantitative and qualitative variations during
astroglial diﬀerentiation.
The proliferative and undiﬀerentiated status has been
demonstrated by immunoﬂuorescence and western blotting.A. Cimini et al. 7
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Figure 7: Western blotting and relative densitometric analysis in S10 neurosphere cell lysates. An example of western blotting is shown.
Densitometric data are means ± SD of 5 diﬀerent experiments. ∗, P<. 05; ∗∗, P<. 001.
BrdU incorporation demonstrates that almost all cells of the
neurospheres are proliferative and the presence of nestin and
PLP, in the absence of markers of diﬀerentiation such as
GFAP, β-tubulin III, and O4, is cosistent with the undiﬀer-
entiated status and allows to conclude that the cellular popu-
lation of our neurospheres is constituted by undiﬀerentiated
cells [22].
The strongly polarized immunolocalization of nestin
suggests that the cells are dividing by asymmetric divisions.
In fact, recent studies have demonstrated that, in stem cells,
some proteins exhibit diﬀerent distribution according to
their division modality [23, 24].
The result that neural stem cells possess all three PPAR
isotypes is new and unexpected. In fact, one would have hy-
pothesized that PPARβ could be the most abundant owing to
its relevantpresenceandearlyexpressionduring braindevel-
opment [15] and owing to its involvement in cell prolifera-
tion and in the ﬁrst stages of cellular diﬀerentiation [25–27].
Our results demonstrate that all three PPARs are expressed
and that they have a nuclear localization in agreement with
their function as transcription factors.
It is known that PPARs act in heterodimeric form
with RXRs. The immunoblotting data reveal that in neural
stem cells only RXRβ is present. This ﬁnding is in agree-
ment with previous results demonstrating this isotype as
the mainly present in rodent brain [28, 29] and suggests
that one or more PPAR isotypes may heterodimerize with
RXRβ.8 PPAR Research
∗∗ 50
0
R
.
U
.
PPARα mRNA
S0
S10
S0 S10
PPARα 741bp
β-actin 661bp
∗∗
50
0
R
.
U
.
PPARβ mRNA
S0
S10
β-actin 661bp
PPARβ/δ 130bp
50
0
R
.
U
.
PPARγ mRNA
S0
S10
β-actin 661bp
PPARγ 421bp
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(a) (b)
Figure 9: Double oil red/nestin in S0 neurospheres (a) and oil
red/GFAP in S10 (b) neurospheres. Bar = 20μm.
The simultaneous presence of the three PPARs in the nu-
cleus does not indicate that they are all transcriptionally ac-
tive;infactithasbeenproposedthatunligandedPPARβ may
act as potent inhibitor of the transcriptional activity of the α
andγ isotypes[30].Itispossibletohypothesizethatinneural
stem cells PPARβ contributes to the maintenance of the un-
diﬀerentiated, proliferative status, by regulating both genes
involved in cell cycle control, as observed in other cell types
[18, 31, 32], and inhibiting the activity of the other PPARs,
which may be, in turn, involved in cellular diﬀerentiation
[13, 14].
The ﬁnding of large lipid droplets in the cytoplasm of
NSC is new and suggests a role for PPARγ in this phe-
nomenon. In fact, the importance of this transcription fac-
tor is well known in adipocyte diﬀerentiation as well as in
cellular types where lipidogenesis occurs, such as oligoden-
drocytes and macrophages [33, 34]. In agreement with this
hypothesis, the PPARγ appears to be strongly expressed both
at mRNA level and at protein level in undiﬀerentiated NSC.A. Cimini et al. 9
When NSC were subjected to astroglial diﬀerentiation,
as expected, GFAP was highly expressed and the nestin was
signiﬁcantly decreased. Moreover, its intracellular distribu-
tion is completely diﬀerent from S0 neurospheres, with the
asymmetrical concentration of the protein in the juxtanu-
clear region being no more observed. The persistance of
nestininthesediﬀerentiatedcellsisconsistentwithdatafrom
otherauthorsthathavereported a coexpressionof GFAPand
nestin in astrocytes in culture from postnatal animals; this
coexpression, which is not observed in vivo, is induced by in
vitro conditions and in vivo during astrogliosis [14, 35].
In the S10 cells, PPARs undergo quantitative modiﬁca-
tions. A modulation of PPARs both at protein and mRNA
levels is observed. The observed strong decrease of PPARβ is
particularlyinteresting, sinceitcouldindicate theremovalor
reduction of its inhibitory eﬀect on the other PPARs [30]. In
this respect, PPARβ might be considered as inhibitor of as-
troglial diﬀerentiation [30, 36]. PPARγ does not vary, both
at mRNA and protein levels, while PPARα is signiﬁcantly in-
creased only at mRNA level. This might be due to the fact
that the RT-PCR and western blotting analyses were per-
formed after 5days of diﬀerentiation in vitro. Probably, to
observe a signiﬁcant increase of the protein, a longer time
should be tested. However, the increase of PPARα suggests a
role for this transcription factor in astroglial diﬀerentiation,
supported by our previous ﬁndings on astrocyte in in vitro
diﬀerentiation [14]. Moreover, the appearance of RXRα,i t s
heterodimeric pattern [29], is in agreement with this sugges-
tion. As regards RXRs, during NSC astroglial diﬀerentiation,
the data obtained demonstrate that RXRγ is never expressed,
in agreement with its restricted localization in adult brain
[29, 37], RXRβ remains unchanged, while RXRα is expressed
de novo by diﬀerentiated cells. Thus, a downregulation of
PPARβ, accompanied by PPARα and RXRα increase may be
a condition for the diﬀerentiation toward astroglial lineage.
As regards PPARγ, the fact that this receptor is not
modiﬁed may indicate that it is not crucial for astrocyte
diﬀerentiation, at least concerning the diﬀerentiation of type
I astrocytes. However, the presence of some A2B5/GFAP
immunopositive cells may indicate that, in our experimental
conditions, diﬀerentiation toward type II astrocytes may also
occur. Since type II astrocytes share a common progenitor
with oligodendrocytes, the O2A cells, the persistence of
PPARγ in diﬀerentiating neurospheres could indicate that
it may be involved in the oligodendrocyte diﬀerentiation
pathway.
Regarding the presence of lipid droplets in undiﬀeren-
tiated cells, their disappearance during diﬀerentiation may
be in agreement with the hypothesis that in our experimen-
tal conditions, the diﬀerentiation toward type I astrocytes is
preferred. In fact, diﬀerentiated astrocytes are able to utilize
lipids as energy fuel [38] through catabolic lipid pathways
requiring PPARα and not PPARγ activity, involved instead in
lipidogenesis.
Overall, the data presented in this work indicate that the
decrease of PPARβ and the concomitant increase and/or ac-
tivation of PPARα together with RXRα are involved in as-
troglial diﬀerentiation of NSC.
In our opinion, however, it should be underlined that the
regulation of diﬀerent diﬀerentiation pathways and/or the
maintenance of undiﬀerentiated status are more aﬀected by
the quantitative ratios existing among the receptors isotypes
(bothPPARsandRXRs)ratherthanbytheabsoluteamounts
of each one of them.
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